이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Becton Dickinson 과거 수익 실적
과거 기준 확인 1/6
Becton Dickinson은 연평균 12.6%의 비율로 수입이 증가해 온 반면, Medical Equipment 산업은 수입이 증가했으며, 연간 8.7%였습니다. 매출은 연평균 3.1%의 비율로 증가했습니다. Becton Dickinson의 자기자본이익률은 5.4%이고 순이익률은 6.9%입니다.
주요 정보
12.6%
수익 성장률
11.4%
EPS 성장률
Medical Equipment 산업 성장 | 8.9% |
매출 성장률 | 3.1% |
자기자본 수익률 | 5.4% |
순이익 | 6.9% |
다음 실적 업데이트 | 01 Aug 2024 |
최근 과거 실적 업데이트
Recent updates
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
May 24Becton, Dickinson and Company: Stagnating All Along
May 16Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?
Mar 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Mar 05Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use
Feb 21Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test
Feb 08Becton, Dickinson Q1 2023 Earnings Preview
Feb 01Becton, Dickinson declares $0.91 dividend
Jan 24We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Jan 09CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod
Jan 09Becton, Dickinson: A Quality Defensive Pick For 2023
Dec 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Dec 01Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91
Nov 13Becton, Dickinson Q4 2022 Earnings Preview
Nov 09Becton, Dickinson, Biocorp team up for traceability of injectable drugs
Oct 18수익 및 비용 분석
수익 및 비용 분석
Becton Dickinson 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
31 Mar 24 | 19,716 | 1,364 | 4,829 | 1,175 |
31 Dec 23 | 19,492 | 1,265 | 4,843 | 1,214 |
30 Sep 23 | 19,372 | 1,470 | 4,817 | 1,237 |
30 Jun 23 | 19,046 | 1,582 | 4,848 | 1,256 |
31 Mar 23 | 18,809 | 1,556 | 4,791 | 1,266 |
31 Dec 22 | 18,738 | 1,486 | 4,751 | 1,255 |
30 Sep 22 | 18,870 | 1,545 | 4,726 | 1,256 |
30 Jun 22 | 18,958 | 1,412 | 4,774 | 1,324 |
31 Mar 22 | 18,924 | 1,430 | 4,845 | 1,339 |
31 Dec 21 | 18,534 | 1,079 | 4,750 | 1,302 |
30 Sep 21 | 19,131 | 1,514 | 4,720 | 1,279 |
30 Jun 21 | 19,066 | 1,486 | 4,632 | 1,210 |
31 Mar 21 | 18,313 | 1,379 | 4,409 | 1,142 |
31 Dec 20 | 18,207 | 1,507 | 4,346 | 1,117 |
30 Sep 20 | 16,074 | 245 | 4,178 | 1,039 |
30 Jun 20 | 16,917 | 786 | 4,216 | 1,067 |
31 Mar 20 | 17,414 | 923 | 4,313 | 1,057 |
31 Dec 19 | 17,355 | 760 | 4,379 | 1,044 |
30 Sep 19 | 17,290 | 1,081 | 4,334 | 1,032 |
30 Jun 19 | 17,108 | 784 | 4,345 | 1,039 |
31 Mar 19 | 17,036 | 926 | 4,353 | 1,063 |
31 Dec 18 | 17,063 | 894 | 4,325 | 1,071 |
30 Sep 18 | 15,983 | 159 | 4,029 | 1,004 |
30 Jun 18 | 14,747 | 621 | 3,689 | 947 |
31 Mar 18 | 13,503 | -99 | 3,325 | 857 |
31 Dec 17 | 12,251 | 294 | 2,991 | 783 |
30 Sep 17 | 12,093 | 1,030 | 2,953 | 770 |
30 Jun 17 | 12,158 | 759 | 2,947 | 807 |
31 Mar 17 | 12,321 | 1,314 | 2,957 | 827 |
31 Dec 16 | 12,419 | 1,309 | 2,966 | 823 |
30 Sep 16 | 12,483 | 976 | 3,005 | 828 |
30 Jun 16 | 12,312 | 1,139 | 2,966 | 771 |
31 Mar 16 | 12,234 | 810 | 2,988 | 743 |
31 Dec 15 | 11,217 | 688 | 2,767 | 690 |
30 Sep 15 | 10,282 | 695 | 2,563 | 632 |
30 Jun 15 | 9,410 | 815 | 2,350 | 570 |
31 Mar 15 | 8,448 | 1,079 | 2,127 | 529 |
31 Dec 14 | 8,468 | 1,150 | 2,141 | 527 |
30 Sep 14 | 8,446 | 1,185 | 2,145 | 524 |
30 Jun 14 | 8,345 | 974 | 2,117 | 522 |
31 Mar 14 | 8,239 | 941 | 2,102 | 506 |
31 Dec 13 | 8,169 | 930 | 2,091 | 502 |
30 Sep 13 | 8,054 | 929 | 2,059 | 494 |
30 Jun 13 | 7,920 | 1,114 | 2,004 | 490 |
양질의 수익: BDX 에는 $750.0M 큰 일회성 손실이 있습니다. $750.0M 은 지난 12개월 간의 재무 결과에 31st March, 2024 까지 영향을 미쳤습니다.
이익 마진 증가: BDX 의 현재 순이익 이익률 (6.9%) 작년보다 낮습니다 (8.3%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: BDX 의 수입은 지난 5년 동안 매년 12.6% 씩 증가했습니다.
성장 가속화: BDX 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: BDX 은 지난 1년 동안 마이너스 수익 성장( -12.3% )을 기록하여 Medical Equipment 업계 평균( 2.4% ).
자기자본 수익률
높은 ROE: BDX 의 자본 수익률( 5.4% )은 낮음으로 간주됩니다.